Clinical trials
Phase 2 Diabetes Mellitus trials in Hungary
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Pfizer | 2 |
| Akros Pharma Inc. | 1 |
| Astellas Pharma Inc | 1 |
| Bayer | 1 |
| Biogen | 1 |
| GlaxoSmithKline | 1 |
| N-Gene Research Laboratories, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Novo Nordisk A/S | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 16 |
| Diabetes Mellitus, Type 2 | 6 |
| Proteinuria | 3 |
| Diabetic Retinopathy | 2 |
| Hyperglycemia | 2 |
| Hyperlipidemias | 2 |
| Obesity | 2 |
| Diabetes Mellitus, Lipoatrophic | 1 |
| Diabetic Nephropathies | 1 |
| Dyslipidemias | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.